Aclaris Therapeutics, Inc. Insider Trading for March 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aclaris Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Aclaris Therapeutics, Inc. for March 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | M | 0.00 | 52,564 | 0 | 0 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | A | 0.00 | 52,564 | 0 | 52,564 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | A | 0.00 | 73,015 | 0 | 73,015 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | A | 0.00 | 146,029 | 0 | 146,029 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | A | 1.26 | 255,552 | 321,996 | 255,552 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | M | 0.00 | 96,150 | 0 | 288,450 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Payment of Exercise | F | 1.26 | 15,101 | 19,027 | 1,034,893 | 1 M to 1 M (-1.44 %) |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Buy | M | 0.00 | 52,564 | 0 | 1,049,994 | 997.4 K to 1 M (+5.27 %) |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Payment of Exercise | F | 1.26 | 27,623 | 34,805 | 997,430 | 1 M to 997.4 K (-2.69 %) |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Buy | M | 0.00 | 96,150 | 0 | 1,025,053 | 928.9 K to 1 M (+10.35 %) |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | SCHIFF ANDREW N | Director | Option Exercise | M | 0.00 | 8,876 | 0 | 0 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | SCHIFF ANDREW N | Director | Option Exercise | A | 0.00 | 8,876 | 0 | 8,876 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | SCHIFF ANDREW N | Director | Buy | M | 0.00 | 8,876 | 0 | 8,876 | 0 to 8.9 K |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Reasons Bryan M. | Director | Option Exercise | M | 0.00 | 8,876 | 0 | 0 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Reasons Bryan M. | Director | Option Exercise | A | 0.00 | 8,876 | 0 | 8,876 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Reasons Bryan M. | Director | Buy | M | 0.00 | 8,876 | 0 | 8,876 | 0 to 8.9 K |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Powell Andrew Kenneth William | Director | Option Exercise | M | 0.00 | 8,876 | 0 | 0 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Powell Andrew Kenneth William | Director | Option Exercise | A | 0.00 | 8,876 | 0 | 8,876 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Powell Andrew Kenneth William | Director | Buy | M | 0.00 | 8,876 | 0 | 9,376 | 500 to 9.4 K (+1,775.20 %) |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Molineaux Christopher P. | Director | Option Exercise | M | 0.00 | 8,876 | 0 | 0 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Molineaux Christopher P. | Director | Option Exercise | A | 0.00 | 8,876 | 0 | 8,876 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Molineaux Christopher P. | Director | Buy | M | 0.00 | 8,876 | 0 | 16,558 | 7.7 K to 16.6 K (+115.54 %) |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Mehra Anand | Director | Option Exercise | M | 0.00 | 8,876 | 0 | 0 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Mehra Anand | Director | Option Exercise | A | 0.00 | 8,876 | 0 | 8,876 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Mehra Anand | Director | Buy | M | 0.00 | 8,876 | 0 | 8,876 | 0 to 8.9 K |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | GOWEN MAXINE | Director | Option Exercise | M | 0.00 | 4,438 | 0 | 0 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | GOWEN MAXINE | Director | Option Exercise | A | 0.00 | 4,438 | 0 | 4,438 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | GOWEN MAXINE | Director | Buy | M | 0.00 | 4,438 | 0 | 4,438 | 0 to 4.4 K |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | A | 0.00 | 26,551 | 0 | 26,551 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | A | 0.00 | 66,377 | 0 | 66,377 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | A | 1.26 | 92,928 | 117,089 | 92,928 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | M | 0.00 | 17,175 | 0 | 51,525 | |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Payment of Exercise | F | 1.26 | 4,779 | 6,022 | 99,199 | 104 K to 99.2 K (-4.60 %) |
| Mar 04 2020 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Buy | M | 0.00 | 17,175 | 0 | 103,978 | 86.8 K to 104 K (+19.79 %) |